Guus van Scharrenburg

Antigenic Relationships between Pore Proteins of <i>Escherichia coli</i> K12

Nico Overbeeke, Guus van Scharrenburg, Ben Lugtenberg · European Journal of Biochemistry · 1980 · 72 citations · Full text

In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): A novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist

Jeffrey Glennon, Guus van Scharrenburg, Eric Ronken et al. · Synapse · 2006 · 39 citations

Vitro Characterization, Dopamine Induction, Psychopharmacology +18

Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease

Juliana Bronzova, Cristina Sampaio, Robert A. Hauser et al. · Movement Disorders · 2010 · 37 citations

Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala

Yukie Kawahara, M.B. Hesselink, Guus van Scharrenburg et al. · European Journal of Pharmacology · 2003 · 36 citations

Orphanin Fq/nociceptin, Neurophysiology, Neuroanatomy +13

An in vivo pharmacological evaluation of pardoprunox (SLV308) — A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease

Caitlin A. Jones, Louisa C. Johnston, Michael S. Jackson et al. · European Neuropsychopharmacology · 2010 · 33 citations

Molecular Pharmacology, Medicine, Neuropharmacology +10